GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
admin By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read Morearticle_normal
German industry expanded in September, despite slowdown in demand, energy crisis
Germany’s industrial production rose in September, beating expectations even as demand for goods moderated and…
Read MoreRyanair swings to net profit as revenue soars, but says rest of year looks fragile
Ryanair Holdings PLC said Monday that it swung to a net profit for the first…
Read MoreWalgreens subsidiary nears $9 billion deal to merge with Summit Health
A unit of Walgreens Boots Alliance Inc. WBA, +3.72% is nearing a deal to combine…
Read MoreChina’s October exports miss expectations as global demand weakens
BEIJING — China’s exports unexpectedly fell in October, dragged by weakening global demand, official data…
Read MoreSharp Corp. shares decline after guidance cut
Sharp Corp. 6753, -2.82% shares fell Monday, after the Japanese electronic products maker lowered its…
Read MoreSanrio shares jump after the Hello Kitty owner boosts guidance
Sanrio Co. 8136, +13.92% shares rose sharply Monday morning after the owner of Hello Kitty…
Read More‘Free-speech absolutist’ Elon Musk cracks down on parody accounts targeting him
Self-proclaimed “free-speech absolutist” Elon Musk announced a crackdown Sunday on parody Twitter accounts impersonating him,…
Read MorePeabody, Australia’s Coronado end talks over potential merger
SYDNEY — Coronado Global Resources Inc. and Peabody Energy Corp. mutually agreed to end talks…
Read More‘Free-speech absolutist’ Elon Musk cracks down on parody accounts targeting him
Self-proclaimed “free-speech absolutist” Elon Musk announced a crackdown Sunday on parody Twitter accounts impersonating him,…
Read More